PRDM5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.791200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.711800E-01
Normal-vs-Stage2
8.598400E-01
Normal-vs-Stage3
4.023800E-01
Normal-vs-Stage4
7.242400E-01
Stage1-vs-Stage2
6.677800E-02
Stage1-vs-Stage3
1.017650E-01
Stage1-vs-Stage4
5.957000E-01
Stage2-vs-Stage3
3.311800E-01
Stage2-vs-Stage4
4.556000E-01
Stage3-vs-Stage4
1.169200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.588600E-01
Normal-vs-AfricanAmerican
7.110000E-01
Normal-vs-Asian
8.445000E-01
Caucasian-vs-AfricanAmerican
3.499800E-01
Caucasian-vs-Asian
9.219200E-01
AfricanAmerican-vs-Asian
4.223200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.212800E-01
Normal-vs-Female
8.399200E-01
Male-vs-Female
7.131400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.818400E-01
Normal-vs-Age(41-60Yrs)
9.082400E-01
Normal-vs-Age(61-80Yrs)
8.689400E-01
Normal-vs-Age(81-100Yrs)
7.857400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.095050E-03
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.77510000032299E-07
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.900100E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.122200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.471000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.530800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.936600E-01
Normal-vs-Daily Drinker
2.729600E-01
Normal-vs-Weekly Drinker
7.668400E-01
Normal-vs-Occasional Drinker
4.548800E-01
Normal-vs-Social Drinker
5.223400E-01
Non Drinker-vs-Daily Drinker
1.807020E-01
Non Drinker-vs-Weekly Drinker
9.920800E-01
Non Drinker-vs-Occasional Drinker
3.050400E-01
Non Drinker-vs-Social Drinker
6.604300E-02
Daily Drinker-vs-Weekly Drinker
3.040400E-01
Daily Drinker-vs-Occasional Drinker
9.610600E-01
Daily Drinker-vs-Social Drinker
1.497710E-02
Weekly Drinker-vs-Occasional Drinker
4.427400E-01
Weekly Drinker-vs-Social Drinker
1.055790E-01
Occasional Drinker-vs-Social Drinker
1.782010E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.35650000010479E-07
Normal-vs-Grade 2
<1E-12
Normal-vs-Grade 3
1.84319226548268E-12
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.828600E-01
Grade 1-vs-Grade 3
2.354800E-01
Grade 1-vs-Grade 4
1.35650000010479E-07
Grade 2-vs-Grade 3
1.768420E-01
Grade 2-vs-Grade 4
<1E-12
Grade 3-vs-Grade 4
1.84319226548268E-12
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.645000E-01
Normal-vs-NonDiabetic
7.051400E-01
Diabetic-vs-NonDiabetic
8.426600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.689000E-01
Normal-vs-NoPancreatitis
7.356400E-01
Pancreatitis-vs-NoPancreatitis
9.480800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.986800E-01
Normal-vs-N1
8.359600E-01
N0-vs-N1
5.481600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.960800E-01
Normal-vs-TP53-NonMutant
6.575600E-01
TP53-Mutant-vs-TP53-NonMutant
1.324940E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
